You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vaccines

Showing 26 - 50 of 6,216
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2 Trial (CV0701 Bivalent High dose, CV0701 Bivalent Medium dose, CV0701 Bivalent Low dose)

Not yet recruiting
  • SARS-CoV-2
  • CV0701 Bivalent High dose
  • +4 more
  • (no location specified)
Jul 24, 2023

Recurrent or Metastatic Bladder Cancer Trial in Shanghai (Chimeric exosomal tumor vaccines)

Recruiting
  • Recurrent or Metastatic Bladder Cancer
  • Chimeric exosomal tumor vaccines
  • Shanghai, China
    Fudan University Pudong Medical Center
Sep 26, 2022

COVID-19 Trial in Johannesburg (AAHI-SC2 Vaccine, AAHI-SC3 Vaccine, EUA or approved vaccine)

Recruiting
  • COVID-19
  • AAHI-SC2 Vaccine
  • +2 more
  • Johannesburg, South Africa
    Wits Vida
Jan 4, 2023

Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Optimized neoantigen synthetic long peptide

Recruiting
  • Pancreas Cancer
  • +2 more
  • Optimized neoantigen synthetic long peptide vaccine
  • Poly-ICLC
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 23, 2023

Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)

Not yet recruiting
  • Tuberculosis
  • BNT164a1
  • +2 more
  • (no location specified)
Jan 18, 2023

Sars-Covid-19 Vaccines in Haematological Patients: Prospective

Completed
  • Hematologic Diseases
  • IgG antibodies to Sars-Cov-2
  • QuantiFERON SARS-CoV-2 test
  • Monza, Lombardia, Italy
    San Gerardo Hospital
Jan 23, 2023

Influenza Trial in Raymond Terrace (OVX836 480µg, Quadrivalent Inactivated Influenza Vaccine (Brand 1), Quadrivalent Inactivated

Not yet recruiting
  • Influenza
  • OVX836 480µg
  • +3 more
  • Raymond Terrace, Brisbane, Australia
    Mater Misericordiae University Hospital
Feb 9, 2023

Assess Immunogenicity of Nationally Authorized Homologous

Not yet recruiting
  • COVID-19
  • Immune Responses
  • (no location specified)
Jan 31, 2023

Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster

Terminated
  • Anti-SARS-CoV-2 Antibody Response
  • blood and saliva samples will be taken
  • Graz, Austria
    Medizinische Universität Graz, Klinische Abteilung für Rheumatol
Jan 9, 2023

Influenza Trial in South Jordan (mRNA-1018 for H5N8, mRNA-1018 for H7N9, mRNA-1018 for H5 Only)

Recruiting
  • Influenza
  • mRNA-1018 for H5N8
  • +4 more
  • South Jordan, Utah
    J. Lewis Research, Inc/Jordan River Family Medicine
Jul 25, 2023

Tuberculosis Trial in Seattle (BCG Vaccine USP, Isoniazid)

Active, not recruiting
  • Tuberculosis
  • Seattle, Washington
    Fred Hutchinson Cancer Center
Dec 9, 2022

Cmv Congenital, CMV Viremia Trial in São Paulo (Women Enrolled, Newborns of Female Study Participants)

Not yet recruiting
  • Cmv Congenital
  • CMV Viremia
  • Women Enrolled
  • Newborns of Female Study Participants
  • São Paulo, Brazil
    University of Sao Paulo
Aug 17, 2022

Chinese COVID-19 Vaccines in Latin America and the Caribbean

Not yet recruiting
  • COVID-19
    • (no location specified)
    Jul 26, 2022

    COVID-19 Vaccines and the Development of New LUTS

    Completed
    • COVID-19 Vaccine Adverse Reaction
    • Lower Urinary Tract Symptoms
      • Zarqa, Jordan
        The Hashemite University
      Oct 14, 2022

      Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),

      Not yet recruiting
      • Poliomyelitis
      • Novel oral poliomyelitis vaccine type 1 (nOPV1)
      • +3 more
      • Dhaka, Bangladesh
        International Centre for Diarrhoeal Disease Research
      Nov 14, 2023

      Vaccine Confidence and Uptake of Potential COVID-19 Vaccines

      Recruiting
      • Coronavirus
      • Survey research
      • Greenville, North Carolina
        Carol Belk Building
      Sep 8, 2022

      Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

      Not yet recruiting
      • Covid-19 Pandemics
      • Tuberculosis
      • Pfizer-BioNTech COVID-19 vaccine
      • +2 more
      • Mae Sot, Tak, Thailand
        Shoklo Malaria Research Unit (SMRU)
      Oct 21, 2022

      COVID-19 Trial in Jakarta (ABO1009-DP, ABO-CoV.617.2, Placebo)

      Recruiting
      • COVID-19
      • ABO1009-DP
      • +2 more
      • Jakarta, Indonesia
      • +1 more
      Jul 25, 2022

      Influenza Trial in Portland, Temple (Flublok, Flucelvax, Fluarix)

      Completed
      • Influenza
      • Flublok
      • +4 more
      • Portland, Oregon
      • +1 more
      Jul 26, 2022

      SafeTy and Efficacy of Preventative CoVID Vaccines

      Active, not recruiting
      • COVID-19 Virus Infection
      • Vaccine Response
      • mRNA Vaccines or Viral vector-based vaccines for COVID
      • Toronto, Ontario, Canada
        University Health Network
      May 19, 2022

      A Study to Evaluate Vaccines Against COVID-19 in the Real World

      Withdrawn
      • Chronic Liver Disease
      • Hepatic Carcinoma
        • Hong Kong, Hong Kong
          Humanity & Health Medical Group
        Aug 1, 2022

        Multiple Sclerosis Trial in Germany (Ofatumumab)

        Active, not recruiting
        • Multiple Sclerosis
        • Berlin, Germany
        • +5 more
        Jan 13, 2023

        SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in

        Recruiting
        • COVID-19
          • Baltimore, Maryland
          • +1 more
          Feb 2, 2023

          Ebola Virus Disease Trial in Goma, Kinshasa (Zabdeno® booster, Ervebo® booster)

          Not yet recruiting
          • Ebola Virus Disease
          • Zabdeno® booster
          • Ervebo® booster
          • Goma, Congo, The Democratic Republic of the
          • +1 more
          Nov 6, 2023

          Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19

          Recruiting
          • Covid-19
          • Pre-COVID-19
          • +2 more
          • Oxford, United Kingdom
            Research site
          Jul 29, 2022